BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel
ENZO BIOCHEM, Inc. (NY: ENZ)
4.390 USD  +0.100 (+2.33%)
Official Closing Price  /  Updated: 4:15 PM EDT, Apr 24, 2014  /  Add to My Watchlist      
(ENZ) Community Analysis from
Bulls REASONS TO BUY
Bears REASONS TO SELL
April 24, 2014
(Benzinga, 10/14/10)
Enzo Biochem Inc. (NYSE: ENZ) reports Q3 earnings loss of $0.15 versus consensus of $0.09 loss. Enzo Biochem Inc. reports revenues of $24.9 million versus consensus of $24.58 million. Cash, cash equivalents and short-term investments...(read more)
(Benzinga, 10/14/10)
Enzo Biochem, Inc. (NYSE: ENZ) today reported results for the fiscal fourth quarter, consistent with our announcement on September 20, 2010, and for the year ended July 31, 2010. In the fourth quarter of fiscal 2010, compared to a...(read more)
(Contrarian Profits, 6/6/08)
I recently got a letter from a reader wondering what I thought about Enzo BioChem (ENZ). ENZ is a life sciences and biotechnology company that provides diagnostic services to the medical...(read more)
Enzo Biochem (ENZ) Company Overview

There is no analysis for ENZ yet. But you can go to Wikinvest to help create one!


Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here